Literature DB >> 21343896

White matter lesions in Parkinson disease.

Nicolaas I Bohnen1, Roger L Albin.   

Abstract

Pure vascular parkinsonism without evidence of nigral Lewy body pathology may occur as a distinct clinicopathological entity, but a much more frequent occurrence is the comorbid presence of age-associated white matter lesions (WMLs) in idiopathic Parkinson disease (PD). WMLs are associated with motor and cognitive symptoms in otherwise normal elderly individuals. Comorbid WMLs are, therefore, expected to contribute to clinical symptoms in PD. Studies of WMLs in PD differ with regard to methods of assessment of WML burden and the patient populations selected for analysis, but converging evidence suggests that postural stability and gait motor functions are predominantly affected. WMLs are described to contribute to dementia in Alzheimer disease, and emerging but inconclusive evidence indicates similar effects in PD. In this article, we review the literature addressing the occurrence and impact of WMLs in PD, and suggest that WMLs may exacerbate or contribute to some motor and cognitive deficits associated with PD. We review existing and emerging methods for studying white matter pathology in vivo, and propose future research directions.

Entities:  

Mesh:

Year:  2011        PMID: 21343896      PMCID: PMC3739056          DOI: 10.1038/nrneurol.2011.21

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  88 in total

1.  Association of gait and balance disorders with age-related white matter changes: the LADIS study.

Authors:  H Baezner; C Blahak; A Poggesi; L Pantoni; D Inzitari; H Chabriat; T Erkinjuntti; F Fazekas; J M Ferro; P Langhorne; J O'Brien; P Scheltens; M C Visser; L O Wahlund; G Waldemar; A Wallin; M G Hennerici
Journal:  Neurology       Date:  2008-03-18       Impact factor: 9.910

2.  Vascular parkinsonism: a distinct, heterogeneous clinical entity.

Authors:  M Demirkiran; H Bozdemir; Y Sarica
Journal:  Acta Neurol Scand       Date:  2001-08       Impact factor: 3.209

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.

Authors:  Karlijn F de Laat; Anil M Tuladhar; Anouk G W van Norden; David G Norris; Marcel P Zwiers; Frank-Erik de Leeuw
Journal:  Brain       Date:  2010-12-14       Impact factor: 13.501

5.  Axial signs and magnetic resonance imaging correlates in Parkinson's disease.

Authors:  Hernish J Acharya; Thomas P Bouchard; Derek J Emery; Richard M Camicioli
Journal:  Can J Neurol Sci       Date:  2007-02       Impact factor: 2.104

6.  Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Authors:  Sun-Ah Choi; Virgilio Gerald Hilario Evidente; John N Caviness; Holly A Shill; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2009-12-03       Impact factor: 17.088

7.  White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study.

Authors:  G Gattellaro; L Minati; M Grisoli; C Mariani; F Carella; M Osio; E Ciceri; A Albanese; M G Bruzzone
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-02       Impact factor: 3.825

8.  The effect of vascular disease on late onset Parkinson's disease.

Authors:  S Papapetropoulos; J Ellul; A A Argyriou; P Talelli; E Chroni; T Papapetropoulos
Journal:  Eur J Neurol       Date:  2004-04       Impact factor: 6.089

9.  Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs.

Authors:  Elan D Louis; Adam M Brickman; Charles DeCarli; Scott A Small; Karen Marder; Nicole Schupf; Truman R Brown
Journal:  Arch Neurol       Date:  2008-12

Review 10.  White matter hyperintensities in late life depression: a systematic review.

Authors:  L L Herrmann; M Le Masurier; K P Ebmeier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-23       Impact factor: 10.154

View more
  84 in total

1.  Dysfunctional white-matter networks in medicated and unmedicated benign epilepsy with centrotemporal spikes.

Authors:  Yuchao Jiang; Li Song; Xuan Li; Yaodan Zhang; Yan Chen; Sisi Jiang; Changyue Hou; Dezhong Yao; Xiaoming Wang; Cheng Luo
Journal:  Hum Brain Mapp       Date:  2019-04-01       Impact factor: 5.038

2.  Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.

Authors:  Christina Sundal; Shinsuke Fujioka; Jay A Van Gerpen; Christian Wider; Alexandra M Nicholson; Matt Baker; Elizabeth A Shuster; Jan Aasly; Salvatore Spina; Bernardino Ghetti; Sigrun Roeber; James Garbern; Alex Tselis; Russell H Swerdlow; Bradley B Miller; Anne Borjesson-Hanson; Ryan J Uitti; Owen A Ross; A Jon Stoessl; Rosa Rademakers; Keith A Josephs; Dennis W Dickson; Daniel Broderick; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2013-06-17       Impact factor: 4.891

3.  Exploring diagnosis and imaging biomarkers of Parkinson's disease via iterative canonical correlation analysis based feature selection.

Authors:  Luyan Liu; Qian Wang; Ehsan Adeli; Lichi Zhang; Han Zhang; Dinggang Shen
Journal:  Comput Med Imaging Graph       Date:  2018-04-04       Impact factor: 4.790

4.  Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease.

Authors:  Manju Liu; Haibo Xu; Yuhui Wang; Yi Zhong; Shuang Xia; David Utriainen; Tao Wang; E Mark Haacke
Journal:  J Vasc Surg       Date:  2014-03-19       Impact factor: 4.268

5.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Natalia Zarzhevsky; Robert A Koeppe; Christopher W Bogan; Michael R Kilbourn; Kirk A Frey; Roger L Albin
Journal:  Brain       Date:  2011-06-08       Impact factor: 13.501

6.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

7.  Associations between cerebrovascular risk factors and parkinson disease.

Authors:  Benjamin R Kummer; Iván Diaz; Xian Wu; Ashley E Aaroe; Monica L Chen; Costantino Iadecola; Hooman Kamel; Babak B Navi
Journal:  Ann Neurol       Date:  2019-08-29       Impact factor: 10.422

8.  White matter microstructural integrity and executive function in Parkinson's disease.

Authors:  Catherine Gallagher; Brian Bell; Barbara Bendlin; Matthew Palotti; Ozioma Okonkwo; Aparna Sodhi; Rachel Wong; Laura Buyan-Dent; Sterling Johnson; Auriel Willette; Auriel Wilette; Sandra Harding; Nancy Ninman; Erik Kastman; Andrew Alexander
Journal:  J Int Neuropsychol Soc       Date:  2013-01-15       Impact factor: 2.892

Review 9.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

10.  White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.

Authors:  Swati Rane; Julia Owen; Daniel S Hippe; Brenna Cholerton; Cyrus P Zabetian; Tom Montine; Thomas J Grabowski
Journal:  J Neuroimaging       Date:  2020-09-16       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.